載入...
Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
BACKGROUND. Type 2 diabetes mellitus (T2DM) is prevalent in patients undergoing heart transplant, and in those without preexisting T2DM, posttransplant diabetes mellitus may develop. Both T2DM and posttransplant diabetes mellitus have been associated with increased morbidity and mortality following...
Na minha lista:
| 發表在: | Transplant Direct |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wolters Kluwer Health
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6511439/ https://ncbi.nlm.nih.gov/pubmed/31165085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000885 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|